CRYPTO:INJUSD

Injective Usd Cryptocurrency News

etoro logo Buy INJUSD
*Your capital is at risk
$4.85
-0.0800 (-1.62%)
At Close: Aug 04, 2026
Canary Capital has filed with the U.S. Securities and Exchange Commission to launch the first-ever staked Injective (INJ) exchange-traded fund, aiming to provide institutional investors with regulated
Injective protocol is forming a bullish pennant above major high time frame support. Price is coiling near the value area low, and a breakout backed by volume could trigger a 150% rally toward key Fib
TL;DR Canary Capital is looking to launch the first staked Injective ETF in the U.S., combining direct exposure to the token with staking rewards. The SEC is considering exempting staking from registr
The asset manager filed Thursday with the SEC to debut its Staked INJ ETF, which would allow investors to earn yield on its fund's underlying tokens.
Canary Capital has made history with the filing of the first-ever staked Injective exchange-traded fund (ETF) with the US Securities and Exchange Commission (SEC). The filing has sent the INJ price on
Canary Capital filed for an Injective ETF with partial staking. The network aims to provide DeFi infrastructure and RWA tokenization.
Staking ETFs remain an uncertainty in the U.S., despite an easing regulatory environment under President Donald Trump's pro-crypto administration.
The fund group has submitted proposals in recent months for other funds that would hold litecoin, solana, XRP, HBAR, Sui and others
Injective (INJ) surges with its EVM testnet launch, partnerships with Google Cloud and Deutsche Telekom, and a potential 3x rally. Here's what traders need to know.
Injective (INJ) gains momentum with its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and bullish price action above $13.50.
Injective (INJ) pushes forward with bullish developments, including an EVM testnet launch, institutional ETF filing, and regulatory collaboration, signaling long-term growth prospects.
The blockchain company, which is built specifically for finance, announced it is now working directly with the U.S. Securities and Exchange Commission (SEC). Its goal is to help shape the future of cr
Injective (INJ) surged 15% this week, fueled by its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and growing DeFi adoption.
Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Injective is back in the spotlight after posting a remarkable 27% surge since last Wednesday, joining a broader market awakening as crypto momentum accelerates. The rally comes as Bitcoin hits new all
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE